Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Chaudhury (KHARAGPUR, India), P. Choudhury (KHARAGPUR, India), N. Ghosh (KHARAGPUR, India), M. Joshi (MUMBAI, India), P. Bhattacharyya (KOLKATA, India). NMR serum metabolomics for understanding the pathophysiology of COPD associated PH: A pilot study. 3923

Member's Comments

No comment yet.

Related content which might interest you: To explore mechanisms in obesity-associated asthma using functional proteomics technology: A pilot study Source: International Congress 2017 – Novel mechanisms in asthma Year: 2017 Altered serum metabolomics in COPD: analysis of the SPIROMICS cohort Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018 Serum metabolomic analysis of mustard airway diseases by nuclear magnetic resonance spectrometry: A pilot study Source: International Congress 2015 – Inflammation and remodelling in lung disease Year: 2015 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 GC MS based untargeted metabolomics for understanding the pathophysiology of asthma COPD overlap (ACO) Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 A NMR-based metabolomics approach to the assessment of inhaled pharmacotherapy in patients with COPD Source: International Congress 2019 – Basic research of airway diseases Year: 2019 Observational studies assessing the pharmacological treatment of obstructive lung disease: strengths, challenges and considerations for study design Source: ERJ Open Res, 6 (4) 00044-2020; 10.1183/23120541.00044-2020 Year: 2020 Stability of serum biomarkers and their associations with clinical outcomes in COPD patients and controls: a longitudinal study Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 COPD patients´ perspectives at the time of diagnosis: a qualitative study Source: Eur Respir J 2006; 28: Suppl. 50, 740s Year: 2006 Metabolic profiling detects biomarkers of protein degradation in COPD patients Source: Eur Respir J 2012; 40: 345-355 Year: 2012 Omics in population studies: a molecular epidemiology perspective in chronic airway disease Source: International Congress 2014 – Personalised exposure and gene environment interactions in chronic airway disease: the exposome and epigenome Year: 2014 Patients and families realizing their future with chronic obstructive pulmonary disease - a qualitative study Source: International Congress 2017 – Nursing practice across respiratory care pathways Year: 2017 An international prospective cohort study to develop a practical COPD disease risk index that predicts the clinical course of COPD Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009 Is poor asthma self-management due to failure to recognise symptoms or failure to act? Novel insights from mining large-scale clinical observational study Source: International Congress 2019 – M-health/e-health II Year: 2019 Training-induced effects on plasma metabolomics in patients with COPD Source: Annual Congress 2008 - Discovery of novel targets in lung disease by means of functional genomics Year: 2008 Recent advances in COPD: pathophysiology, respiratory physiology and clinical aspects, including comorbidities Source: Eur Respir Rev 2009; 18: 198-212 Year: 2009 CIPHER: a prospective, multicentre study for the identification of biomarker signatures for early detection of pulmonary hypertension Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients Source: International Congress 2016 – From microimaging to functional evaluation of the lung Year: 2016 2D cross-omics integrated enrichment analysis reveals insights into COPD pathogenesis Source: International Congress 2017 – New Mechanistic Findings in COPD Year: 2017